These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31135263)

  • 1. Two-stage adaptive enrichment design for testing an active factor.
    Ding AA; Wu SS; Dean NE; Zahigian RS
    J Biopharm Stat; 2020; 30(1):18-30. PubMed ID: 31135263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial.
    George SZ; Staud R; Borsa PA; Wu SS; Wallace MR; Greenfield WH; Mackie LN; Fillingim RB
    Contemp Clin Trials; 2017 May; 56():9-17. PubMed ID: 28315479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixture-based gatekeeping procedures in adaptive clinical trials.
    Kordzakhia G; Dmitrienko A; Ishida E
    J Biopharm Stat; 2018; 28(1):129-145. PubMed ID: 29283310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Goldilocks Design with strict type I error control in confirmatory clinical trials.
    Zhan T; Zhang H; Hartford A; Mukhopadhyay S
    J Biopharm Stat; 2020 Sep; 30(5):821-833. PubMed ID: 32297825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A response adaptive design for ordinal categorical responses.
    Biswas A; Bhattacharya R; Das S
    J Biopharm Stat; 2018; 28(6):1169-1181. PubMed ID: 29504826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomes.
    Takeda K; Morita S; Taguri M
    Pharm Stat; 2020 May; 19(3):335-349. PubMed ID: 31829517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistics Commentary Series. Commentary No. 42: Minimization.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(5):441-442. PubMed ID: 32701908
    [No Abstract]   [Full Text] [Related]  

  • 8. Design optimization for dose-finding trials: a review.
    Aouni J; Bacro JN; Toulemonde G; Colin P; Darchy L; Sebastien B
    J Biopharm Stat; 2020 Jul; 30(4):662-673. PubMed ID: 32183578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response adaptive randomization procedures in seamless phase II/III clinical trials.
    Zhu H; Piao J; Lee JJ; Hu F; Zhang L
    J Biopharm Stat; 2020; 30(1):3-17. PubMed ID: 31454295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a prespecified subgroup.
    Sugitani T; Posch M; Bretz F; Koenig F
    Stat Med; 2018 Oct; 37(24):3387-3402. PubMed ID: 29945304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsychosocial Influence on Shoulder Pain: Influence of Genetic and Psychological Combinations on Twelve-Month Postoperative Pain and Disability Outcomes.
    George SZ; Wu SS; Wallace MR; Moser MW; Wright TW; Farmer KW; Greenfield WH; Dai Y; Li H; Fillingim RB
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1671-1680. PubMed ID: 26945673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization.
    Jiang Y; Zhao W; Durkalski-Mauldin V
    J Biopharm Stat; 2020; 30(1):69-88. PubMed ID: 31017843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis.
    Flight L; Arshad F; Barnsley R; Patel K; Julious S; Brennan A; Todd S
    Value Health; 2019 Apr; 22(4):391-398. PubMed ID: 30975389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal adaptive single-arm phase II trials under quantified uncertainty.
    Kunzmann K; Kieser M
    J Biopharm Stat; 2020; 30(1):89-103. PubMed ID: 31023135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage enrichment clinical trial design with adjustment for misclassification in predictive biomarkers.
    Lin Y; Shih WJ; Lu SE
    Stat Med; 2019 Dec; 38(29):5445-5469. PubMed ID: 31621944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-stage enrichment and basket trial designs with population selection.
    Li W; Zhao J; Li X; Chen C; Beckman RA
    Stat Med; 2019 Dec; 38(29):5470-5485. PubMed ID: 31621949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a biopsychosocial influence on shoulder pain: pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain ratings.
    George SZ; Wallace MR; Wright TW; Moser MW; Greenfield WH; Sack BK; Herbstman DM; Fillingim RB
    Pain; 2008 May; 136(1-2):53-61. PubMed ID: 17686583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsychosocial influence on exercise-induced delayed onset muscle soreness at the shoulder: pain catastrophizing and catechol-o-methyltransferase (COMT) diplotype predict pain ratings.
    George SZ; Dover GC; Wallace MR; Sack BK; Herbstman DM; Aydog E; Fillingim RB
    Clin J Pain; 2008; 24(9):793-801. PubMed ID: 18936597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study.
    Jaki T; Wason JMS
    BMC Cardiovasc Disord; 2018 Nov; 18(1):215. PubMed ID: 30482176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive treatment allocation for comparative clinical studies with recurrent events data.
    Gao J; Su PF; Hu F; Cheung SH
    Biometrics; 2020 Mar; 76(1):183-196. PubMed ID: 31282997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.